M. Bret Schneider

Corporate Officer/Principal bei Stanford University

Consumer Services

Health Technology

Profil

M.
Bret Schneider was the founder of Cervel Neurotech, Inc. which was founded in 2008 where he held the title of Chief Medical Officer.
Currently, he is a Staff Scientist at Stanford University.
Dr. Schneider received his undergraduate degree from Washington University in St. Louis and his doctorate from Rush University.

Aktive Positionen von M. Bret Schneider

Unternehmen	Position	Beginn
Stanford University	Corporate Officer/Principal	-

Alle aktiven Positionen von M. Bret Schneider

Ehemalige bekannte Positionen von M. Bret Schneider

Unternehmen	Position	Ende
Cervel Neurotech, Inc. Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA.	Gründer	-

Sehen Sie sich die Erfahrung von M. Bret Schneider im Detail an

Ausbildung von M. Bret Schneider

Washington University in St. Louis	Undergraduate Degree
Rush University	Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von M. Bret Schneider im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	1
Cervel Neurotech, Inc. Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA.	Health Technology